These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2335616)

  • 1. Cranial MR in phenylketonuria.
    Shaw DW; Weinberger E; Maravilla KR
    J Comput Assist Tomogr; 1990; 14(3):458-60. PubMed ID: 2335616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria).
    Sugita R; Takahashi S; Ishii K; Matsumoto K; Ishibashi T; Sakamoto K; Narisawa K
    J Comput Assist Tomogr; 1990; 14(5):699-703. PubMed ID: 2398144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.
    Phillips MD; McGraw P; Lowe MJ; Mathews VP; Hainline BE
    AJNR Am J Neuroradiol; 2001 Sep; 22(8):1583-6. PubMed ID: 11559511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylketonuria: MR imaging of the brain with clinical correlation.
    Pearsen KD; Gean-Marton AD; Levy HL; Davis KR
    Radiology; 1990 Nov; 177(2):437-40. PubMed ID: 2217781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperphenylalaninemia: CT and MR of the brain.
    Brismar J; Aqeel A; Gascon G; Ozand P
    AJNR Am J Neuroradiol; 1990; 11(1):135-8. PubMed ID: 2105595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of phenylketonuria.
    Shaw DW; Maravilla KR; Weinberger E; Garretson J; Trahms CM; Scott CR
    AJNR Am J Neuroradiol; 1991; 12(3):403-6. PubMed ID: 2058482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla.
    Kornguth S; Anderson M; Markley JL; Shedlovsky A
    Neuroimage; 1994 Jun; 1(3):220-9. PubMed ID: 9343573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR in phenylketonuria-related brain lesions.
    Dezortová M; Hájek M; Tintera J; Hejcmanová L; Syková E
    Acta Radiol; 2001 Sep; 42(5):459-66. PubMed ID: 11552882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
    Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
    Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No white matter abnormalities in untreated patients with persistent hyperphenylalaninaemia: findings in magnetic resonance imaging. German PKU Collaborative Study.
    Weglage J; Ullrich K; Schuierer G; Pietsch M; Fünders B
    Eur J Pediatr; 1994 Dec; 153(12):918-9. PubMed ID: 7859796
    [No Abstract]   [Full Text] [Related]  

  • 19. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliotic, nodular lesions in phenylketonuria: MR imaging findings.
    Sener RN
    Comput Med Imaging Graph; 1996; 20(5):399-401. PubMed ID: 9007368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.